Join
Live feed
·
INSIDERFilingvia Quantisnow
AbCellera Biologics Inc. logo

SEC Form 4: Thermopylae Holdings Ltd. bought $483,965 worth of shares (64,545 units at $7.50), increasing direct ownership by 0.12% to 55,580,303 units

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ABCL (AbCellera Biologics Inc.) and more on Quantisnow.